Mix Vaccine for Metastatic Sarcoma Patients

Status Completed

Clinical Trial Summary

The aim of this study is the safety and efficacy of mix vaccine to small metastases of sarcoma.

Clinical Trial Description

By enrolling patients with small metastases of sarcoma adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03357315
Study type	Interventional
Source	Fuda Cancer Hospital, Guangzhou
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	November 30, 2017
Completion date	August 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04457258` - 68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma	Early Phase 1
Withdrawn	`NCT04906876` - A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas	Phase 2
Completed	`NCT01106872` - Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas	Phase 1
Terminated	`NCT03520959` - A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)	Phase 3
Completed	`NCT01112384` - A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas	Phase 2
Active, not recruiting	`NCT05448820` - YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma	Phase 1/Phase 2
Active, not recruiting	`NCT04595747` - Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)	Phase 2
Not yet recruiting	`NCT06298916` - 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer	Phase 1/Phase 2
Recruiting	`NCT04693377` - Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial	N/A
Recruiting	`NCT03168061` - Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma	Phase 1/Phase 2
Not yet recruiting	`NCT05835154` - A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma	N/A
Not yet recruiting	`NCT04199026` - Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma	Early Phase 1
Not yet recruiting	`NCT06235125` - Safety and Feasibility of Intraoperative Visualization With Cytalux in Children	Phase 1
Recruiting	`NCT04771520` - Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors	Phase 2
Recruiting	`NCT05711615` - Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma	Phase 1
Completed	`NCT03823144` - Intravital Microscopy in Human Solid Tumors	N/A
Recruiting	`NCT04430725` - Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
Completed	`NCT02192346` - α-TEA in Advanced Cancer	Phase 1
Completed	`NCT02448537` - A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas	Phase 2
Terminated	`NCT02609984` - Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002)	Phase 2